Financhill
Back

Crinetics Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$37.24
Seasonality Move:
6.81%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is relatively stagnant and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Crinetics Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 35.64 Buy
20-day SMA: 36.36 Buy
50-day SMA: 42.18 Sell
200-day SMA: 39.83 Sell
8-day EMA: 36.06 Buy
20-day EMA: 37.06 Buy
50-day EMA: 40.53 Sell
200-day EMA: 41.45 Sell

Crinetics Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.67 Sell
Relative Strength Index (14 RSI): 46.65 Sell
Chaikin Money Flow: 1144076 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.19 - 39.01) Buy
Bollinger Bands (100): (39.09 - 50.79) Sell

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Crinetics Pharmaceuticals, Inc. Stock

Is Crinetics Pharmaceuticals, Inc. Stock a Buy?

CRNX Technical Analysis vs Fundamental Analysis

Sell
27
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy or a Sell?

Crinetics Pharmaceuticals, Inc. Stock Info

Market Cap:
4B
Price in USD:
37.23
Share Volume:
1.2M

Crinetics Pharmaceuticals, Inc. 52-Week Range

52-Week High:
57.99
52-Week Low:
24.10
Sell
27
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Crinetics Pharmaceuticals, Inc. Share Price Forecast

Is Crinetics Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Crinetics Pharmaceuticals, Inc.

Is Crinetics Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.14 per share, an increase this year of $0.24 per share, and an increase next year of $0.70 per share.

Technical Analysis of Crinetics Pharmaceuticals, Inc.

Should I short Crinetics Pharmaceuticals, Inc. stock?

* Crinetics Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.